Clinical trial
Evaluation of the Efficacy and Safety of Bladder Injection of Autologous Concentrated Platelets in the Treatment of Refractory Overactive Bladder Disorder
NCT07797647 is registered in ClinicalTrials.gov with Gang Chen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of Bladder Injection of Autologous Concentrated Platelets in the Treatment of Refractory Overactive Bladder Disorder
- Lead sponsor
- Gang Chen
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- April 8, 2026
- Completion date
- December 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
over active bladder